Ernexa Therapeutics Inc.
ERNAW· Nasdaq
Released Aug 3, 2016, after the close
10-Q filed Aug 4, 2016, 35 days after period end · 0001493152-16-011963
| Metric | Q2 2016 | Q2 2015 | Q2 2014 | Q2 2013 |
|---|---|---|---|---|
| Revenue | $5.41M | $6.19M | $6.87M | $5.53M |
| Net Income | -$850.00K | -$2.63M | -$1.35M | -$99.00K |
| EPS Diluted |
Ernexa Therapeutics Inc. · CIK 748592 · Engraved from SEC EDGAR
| -$0.46 |
| -$1.43 |
| -$0.02 |
| $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.